Kidney Stem Cell Clinical Trials

Hickson is part of the research team looking at using stem cells to help regenerate failing kidneys.

Kidney stem cell clinical trials.

Explore all clinical trials at mayo clinic. Learn about volunteering in a clinical trial. Find open clinical trials related to regenerative medicine therapy. Clinical trials are ongoing however with the goal of testing whether such therapies are effective and safe in humans.

This multi pronged approach aims to capitalize on promising translational achievements in the near future while pursing potential drugs and the ultimate goal of. The harvard stem cell institute hsci kidney group has short medium and long term strategies to develop new therapies for diabetes related kidney damage diabetic nephropathy. You are 18 or older. You may be eligible if.

Scientists are working on a promising approach to treat chronic kidney disease and kidney failure by harnessing the unique properties of human amniotic fluid derived stem cells the mixture of stem cells that can be. Click here for their list of clinical trials which are currently. Our goal is to take a look at how we can repair the diabetic kidney in terms of delaying the rate of progression of kidney failure says latonya hickson m d a mayo clinic nephrologist. This phase iii trial compares nephrectomy surgery to remove a kidney or part of a kidney with nivolumab to the usual approach of nephrectomy followed by standard post operative follow up and monitoring in treating patients with kidney cancer that is limited to a certain part of the body localized.

The website clinicaltrials gov has the most up to date information about the status of these trials. Clinical trial of mesenchymal stem cells in the treatment of severe acute kidney injury wed 12 11 2019 12 00 conditions. You have been diagnosed with kidney cancer type clear cell. Diabetic kidney disease also known as diabetic nephropathy is the most common cause of chronic kidney disease and end stage kidney failure requiring dialysis or kidney transplantation.

Study related tests procedures and medications are provided at no cost. Currently there are no stem cell treatments for kidney disease that are approved by the fda. Harvard university dedicates program specifically to kidney stem cell research for ckd and dialysis patients. Regenerative cell based therapy applying mscs holds promise to delay the progression of kidney disease in individuals with diabetes mellitus.

There are currently no fda approved treatments for kidney disease that use stem cells but researchers are conducting clinical trials to test whether stem cell based therapies for kidney diseases are safe and effective in humans. You will stay at the clinical center nih s research hospital for at least 2 weeks after the re infusion of the boostered t cells.